CIPLA receives approval from US FDA
CIPLA receives approval from US FDA

CIPLA receives approval from US FDA

DSIJ Intelligence Article rating: 5.0
Cipla’s Tadalafil Tablets 20mg is AB-rated generic therapeutic equivalent version of Eli Lilly’s Adcirca. It is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability.
Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 3.5

The markets on February 7, 2019 opened gap up. BSE Sensex is trading at 37,108.42, up by 133.19 points and the Nifty is trading at 11,099.80, up by 37.35 points. 

RBI cuts repo rate by 25bps
RBI cuts repo rate by 25bps

RBI cuts repo rate by 25bps

DSIJ Intelligence Article rating: 5.0

The Reserve Bank of India (RBI) reduced policy repo rates under LAF by 25 basis points on Thursday. The Monetary Policy Committee (MPC) also changed its policy stance to neutral.

Minda Industries reports good set of numbers for Q3FY19
Minda Industries reports good set of numbers for Q3FY19

Minda Industries reports good set of numbers for Q3FY19

Amir Shaikh Article rating: 5.0

The net profit for the quarter grew 23 per cent yoy to Rs. 81.3 crore. Net profit margin for the quarter stood at 5.4 per cent. The company's board has declared an interim dividend of Rs. 0.45 per share. 

ENIL posts 36 per cent revenue growth
ENIL posts 36 per cent revenue growth

ENIL posts 36 per cent revenue growth

DSIJ Intelligence Article rating: 5.0

The FM channel (Radio Mirchi) operator reported December quarter results with a total revenue of Rs. 200.89 crore as against revenue of Rs. 147.86 crore in the same period year ago.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 1.09 crore contracts with a turnover of Rs. 6,50,160.10 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 3.5

Overall volumes in futures & options currently stand at 1.09 crore contracts with a turnover of Rs. 6,50,160.10 crore.

RSS
First33983399340034013403340534063407Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR